Glucosamine Supplement Tied to Lower Mortality
Regular use tied to a 65% risk for cardiovascular death
Parenteral Nutrition
Tralement Now Available for Trace Element Supplementation
Tralement is indicated in adult and pediatric patients as a source of zinc, copper, manganese, and selenium for parenteral nutrition.
New Dosage Options of Potassium Phosphates Injection Available From Fresenius Kabi
Potassium Phosphates Injection is a phosphorus replacement product.
FDA-Approved Potassium Phosphates Injection Available
CMP Pharma announced the availability of Food and Drug Administration (FDA)-approved Potassium Phosphates Injection.
FDA-Approved Zinc Sulfate Injection for Parenteral Nutrition Now Available
American Regent has announced the availability of Zinc Sulfate Injection, a trace element indicated as a source of zinc for parenteral nutrition in adult and pediatric patients when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Nouress Approved to Meet Nutritional Requirements of Neonates Requiring TPN
Nouress provides cysteine to the systemic circulation of neonates who require parenteral nutrition and cannot synthesize adequate quantities of cysteine due to deficient cystathionase activity.
Selenious Acid Injection Now Available for Trace Element Supplementation
Selenious Acid Injection is a trace element indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Omegaven Available for Pediatric Parenteral Nutrition-Associated Cholestasis
Fresenius Kabi announced the availability of Omegaven (fish oil triglycerides) injectable emulsion as a source of calories and fatty acids for pediatric patients with parenteral nutrition-associated cholestasis.
Balanced Crystalloids May Cut Kidney Complications Compared With Saline
The results showed no difference in the number of hospital-free days between either group but the balanced crystalloids group had a lower incidence of major adverse kidney events ≤30 days vs the saline group.
First Four-Oil Parenteral Nutrition Product Available
Fresenius Kabi announced the launch of Smoflipid, a parenteral nutrition product, for use in adults.
